U.S. Induced Pluripotent Stem Cells Production Market Size & Outlook
Related Markets
U.S. induced pluripotent stem cells production market highlights
- The U.S. induced pluripotent stem cells production market generated a revenue of USD 581.6 million in 2024 and is expected to reach USD 1,377.9 million by 2033.
- The U.S. market is expected to grow at a CAGR of 10.2% from 2025 to 2033.
- In terms of segment, manual ipsc production process was the largest revenue generating process in 2024.
- Automated iPSC Production Process is the most lucrative process segment registering the fastest growth during the forecast period.
Induced pluripotent stem cells production market data book summary
| Market revenue in 2024 | USD 581.6 million |
| Market revenue in 2033 | USD 1,377.9 million |
| Growth rate | 10.2% (CAGR from 2025 to 2033) |
| Largest segment | Manual ipsc production process |
| Fastest growing segment | Automated iPSC Production Process |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Manual iPSC Production Process, Automated iPSC Production Process |
| Key market players worldwide | Lonza Group Ltd, Axol Bioscience, Evotec SE, Hitachi Ltd, ReproCELL, Merck KGaA, Fate Therapeutics Inc, Thermo Fisher Scientific Inc, Applied StemCell, Stemcell Holdings Inc Ordinary Shares |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.8% of the global induced pluripotent stem cells production market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. induced pluripotent stem cells production market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 1,377.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Induced Pluripotent Stem Cells Production Market Scope
Induced Pluripotent Stem Cells Production Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Applied StemCell | View profile | 11-50 | Milpitas, California, United States, North America | http://www.appliedstemcell.com |
| Axol Bioscience | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | https://www.axolbio.com |
| ReproCELL | View profile | 51-100 | Yokohama, Kanagawa, Japan, Asia | http://reprocell.com |
| Fate Therapeutics Inc | View profile | 181 | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 | https://www.fatetherapeutics.com |
| Evotec SE | View profile | 5055 | Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 | https://www.evotec.com |
| Stemcell Holdings Inc Ordinary Shares | View profile | - | 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 | https://www.stemcell-holdings.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Hitachi Ltd | View profile | 322525 | 6-6, Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan, 100-8280 | http://www.hitachi.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
U.S. induced pluripotent stem cells production market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to induced pluripotent stem cells production market will help companies and investors design strategic landscapes.
Manual ipsc production process was the largest segment with a revenue share of 85.02% in 2024. Horizon Databook has segmented the U.S. induced pluripotent stem cells production market based on manual ipsc production process, automated ipsc production process covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. induced pluripotent stem cells production market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. induced pluripotent stem cells production market databook
-
Our clientele includes a mix of induced pluripotent stem cells production market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. induced pluripotent stem cells production market , including forecasts for subscribers. This country databook contains high-level insights into U.S. induced pluripotent stem cells production market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. induced pluripotent stem cells production market size, by process, 2021-2033 (US$M)
U.S. Induced Pluripotent Stem Cells Production Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
